Company Research Report: Earlybird Venture Capital
Company Overview
- Name: Earlybird Venture Capital
- Mission: To invest in and support European technology innovators across all development and growth phases, offering not just financial resources, but strategic support and access to an international network and capital markets.
- Founded: 1997
- Founders: No specific individual founders are named, but mentions include Dr. Hendrik Brandis, Roland Manger, Dr. Christian Nagel, and Rolf Mathies (In Memoriam) as co-founders.
- Key People:
- Valentin Stalf & Maximilian Tayenthal, CEO & COO (mentioned in relation to the company's value as sparring partners)
- Dr. Hendrik Brandis, Co-Founder and Partner
- Dr. Christian Nagel, Co-Founder and Partner
- Roland Manger, Co-Founder and Partner
- Ben Wilkening, Vision Lab Partner
- Headquarters: No specific location for the headquarters is provided, but offices exist in cities like Berlin, Munich, Paris, Istanbul, Cologne, and others.
- Number of Employees: 81 permanent employees
- Revenue: No information is available.
- Company Recognition: Known for being one of the most established and active venture capital firms in Europe, with EUR 2.5 billion in assets under management.
Products and Services
Investment Funds Offered:
- Digital West Fund: Focuses on early-stage digital technology opportunities in GSA, Nordics, UK, Benelux, France, and Southern Europe.
- Digital East Fund: Targets early-stage ICT investment opportunities in Eastern Europe and Turkey.
- Health Fund: Invests in digital health, medical devices, diagnostics, enabling technologies, and biopharma across Europe.
- Earlybird-X: Focuses on deep tech innovation, including AI, robotics, and mobility, engaging with European universities.
Recent Developments
- Recent Developments and News:
- Launched an incubator and impact fund called "Vision Lab" supporting tech entrepreneurs of migrant backgrounds with a six-month program offering workshops, networking, mentoring, and funding.
- Earlybird Health closed a fresh fund of EUR 173M as of February 2024.
- Published its first ESG and Impact Report for 2022 titled "Innovation for a Healthier World" in July 2023.
- New Products and Features:
- No new singular product launches are noted.
- Notable ESG progression within the Health Fund, including ongoing commitment to sustainability and impact.
- Partnerships:
- Collaborates with partners like Bain & Co., Egon Zehnder, and Handelsblatt in the pro bono Incubator and Impact Fund initiative, Vision Lab.
This report provides a comprehensive overview of Earlybird Venture Capital focusing on its foundational history, core mission, active investment strategies within Europe, and its latest initiatives designed to bolster technological innovation by offering pivotal support to tech startups.
